tm logo

Monitor this mark

View On USPTO

DXM PHARMACEUTICAL
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 31 Oct 2023

Last Applicant/ Owned by

DXM Pharmaceutical, Inc.

2717 Commercial Center Blvd - Suite E200

Houston

TX

77494

Serial Number

87522839 filed on 11th Jul 2017

Registration Number

5460667 registered on 01st May 2018

in the Principal Register

Correspondent Address

Keith B. Willhelm

Keith B. Willhelm

681 N. Post Oak Lane

HOUSTON TX 77024

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

DXM PHARMACEUTICAL

pharmaceutical preparations, namely, over-the-counter cough syrups

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations, namely, over-the-counter cough syrups

First Use Date in General

08th Feb 2018

First Use Date in Commerce

08th Feb 2018

Specimens

DXM PHARMACEUTICAL specimenDXM PHARMACEUTICAL specimen

Mark Details

Serial Number

No 87522839

Mark Type

No Service/Collective Mark

Attorney Docket Number

No DXMP:003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.15.25 -

Other natural phenomena and observable events

27.03.05 -

Representations of objects forming letters or numerals, including punctuation

Legal History

Show more

Status DateAction Taken
31st Oct 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31st Oct 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
31st Oct 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st May 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01st May 2023TEAS SECTION 8 & 15 RECEIVED
01st May 2018REGISTERED-PRINCIPAL REGISTER
27th Mar 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26th Mar 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
16th Mar 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
16th Mar 2018STATEMENT OF USE PROCESSING COMPLETE